3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Pain, Postoperative
12
Brain Neoplasms
8
Breast Neoplasms
5
Agnosia
4
Thyroid Neoplasms
3
Stomach Neoplasms
3
Lung Neoplasms
3
Emergence Delirium
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Pain
2
Inflammation
2
Dexmedetomidine
2
Delirium
2
Chronic Pain
2
Thrombosis
1
Supratentorial Neoplasms
1
Sigmoid Neoplasms
1
Sedation
1
Sarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Pneumoperitoneum
1
Pheochromocytoma
1
Opioid Consumption, Postoperative
1
Neoplasms
1
Neoplasm Metastasis
1
Interventions
Magnetic Resonance Spectroscopy
4
Yoga
2
Sodium Chloride
2
Saline Solution
2
Ropivacaine
2
Proton Therapy
2
Gadolinium DTPA
2
Elasticity Imaging Techniques
2
sintilimab
1
gallium Ga 68 dotatate
1
gadobutrol
1
gadobenic acid
1
apatinib
1
Tranexamic Acid
1
Thrombectomy
1
Surveys and Questionnaires
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Protons
1
Neuropsychological Tests
1
Mind-Body Therapies
1
Meditation
1
Laser Speckle Contrast Imaging
1
Immunoenzyme Techniques
1
Hyperspectral Imaging
1
Heavy Ion Radiotherapy
1
Gelclair
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Meningioma
×
Dexmedetomidine
×
Clear all
NCT07398066
2026-02-09
DEX-NEURO
University of Malaya
Phase NA
Not yet recruiting
60 enrolled